HHMI
RDC

Howard Hughes Medical Institute’s Rowan Companies Plc RDC Stock Holding History

Howard Hughes Medical Institute’s Portfolio RDC Stock Details RDC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-469
Closed -$17K – 221
2013
Q4 		$17K Sell
469
-332
-41% -$11.9K ﹤0.01% 177
2013
Q3 		$29K Buy
+801
New +$28.8K ﹤0.01% 174

Other funds holding RDC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sasco Capital Fairfield, Connecticut $668M AUM 12.79% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Howard Hughes Medical Institute's RDC Position: Q1 2014 in Review

Howard Hughes Medical Institute sold out of Rowan Companies Plc (RDC) in Q1 2014, closing a stake of 469 shares — an estimated $17K sold.

Howard Hughes Medical Institute first reported a position in RDC in Q3 2013 and held it in 2 quarters. The position peaked at $29K in Q3 2013. 297 funds tracked by Wall St. Rank hold RDC as of Q1 2014.

  • Howard Hughes Medical Institute reported no remaining Rowan Companies Plc position as of Q1 2014 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 469 Rowan Companies Plc shares in Q1 2014, an estimated $17K.
  • Howard Hughes Medical Institute first reported a position in Rowan Companies Plc in Q3 2013 and held it in 2 quarters.
  • Howard Hughes Medical Institute's Rowan Companies Plc position peaked at $29K in Q3 2013.
  • 297 funds tracked by Wall St. Rank held Rowan Companies Plc as of Q1 2014.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2014, filed 8 May 2014.